{
    "id": "row_000045",
    "result": "##Title##\nThe Role of Machine and Deep Learning in Pharmacogenomics for Antidepressant Treatment Prediction\n\n##Introduction##\nBased on the provided context, a growing body of evidence suggests that machine learning and deep learning techniques are becoming a vital foundation for the pharmacogenomics of antidepressant treatments, particularly for patients with major depressive disorder (MDD). These advanced computational approaches are being employed to analyze complex biological data and improve treatment outcomes.\n\n##Main Body##\nThe essence of applying machine and deep learning to this field lies in their ability to determine treatment predictions and identify potential biomarkers for antidepressant efficacy. Researchers leverage these algorithms to analyze and integrate diverse datasets, including neuroimaging and multi-omics data. By combining information from pharmacogenomics and neuroimaging, machine learning models can be used to predict how a patient with MDD will respond to a specific antidepressant treatment. The primary goal is to identify various genomic variants and biomarkers associated with treatment response by employing these sophisticated algorithms.\n\n##Conclusion##\nIn summary, the core purpose of using machine and deep learning in pharmacogenomics research for antidepressants is to create predictive models that can identify biomarkers and forecast treatment outcomes. By processing complex, multi-faceted data from genomics and neuroimaging, these techniques aim to pave the way for more personalized and effective treatment strategies for major depressive disorder.",
    "prompt": "You will be given a JSON object as a string which contains a series of related search queries and their retrieved documents ('hits'). Do not make answer from external knowledge. You must make answer inside of Context.\nYour main task is to answer the specific 'Question' provided below. Use the entire JSON data as context to formulate your answer, paying close attention to the 'text' fields within the 'hits' lists.\n\nThe JSON data has a list of queries. The 'original' query is the one you need to answer. The other queries are supplementary and provide additional context.\n\nIf the 'Question' is in Korean, format your answer in Korean as follows:\n##제목##\n\n##서론##\n\n##본론##\n\n##결론##\n\nIf the 'Question' is in English, format your answer in English as follows:\n##Title##\n\n##Introduction##\n\n##Main Body##\n\n##Conclusion##\n\n--- Context (JSON Data) ---\n{\n  \"id\": \"row_000045\",\n  \"model_name\": \"Snowflake/snowflake-arctic-embed-l-v2.0\",\n  \"timestamp_kst\": \"2025-09-07T15:53:08.476963+09:00\",\n  \"trial_id\": \"7843efac\",\n  \"queries\": [\n    {\n      \"query\": \"What is the essence of applying various machine and deep learning approaches to pharmacogenomics research for antidepressant treatment prediction?\",\n      \"query_meta\": {\n        \"type\": \"original\"\n      },\n      \"top_k\": 10,\n      \"hits\": [\n        {\n          \"rank\": 1,\n          \"score\": 0.4918850064277649,\n          \"doc_id\": \"53\",\n          \"text\": \"Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms.\"\n        },\n        {\n          \"rank\": 2,\n          \"score\": 0.46110841631889343,\n          \"doc_id\": \"164\",\n          \"text\": \"Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade 없음\"\n        },\n        {\n          \"rank\": 3,\n          \"score\": 0.44697660207748413,\n          \"doc_id\": \"202\",\n          \"text\": \"Machine learning Machine learning Machine learning A short review of research and applications in machine learning is given. Rather than attempt to cover all areas of ML, the focus is on its role in building expert systems, its approach to classification problems and ML methods of learning control. A relatively new area, inductive logic programming, is also discussed.\"\n        }\n      ]\n    },\n    {\n      \"query\": \"What are the primary challenges in predicting antidepressant treatment response using pharmacogenomic data?\",\n      \"query_meta\": {\n        \"type\": \"single_hop\",\n        \"index\": 0\n      },\n      \"top_k\": 10,\n      \"hits\": [\n        {\n          \"rank\": 1,\n          \"score\": 0.402208149433136,\n          \"doc_id\": \"140\",\n          \"text\": \"Sharing Big Data Sharing Big Data Sharing Big Data Macromolecular Big Data provide numerous challenges and a number of initiatives that are starting to overcome these issues are discussed.\"\n        },\n        {\n          \"rank\": 2,\n          \"score\": 0.39924973249435425,\n          \"doc_id\": \"53\",\n          \"text\": \"Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms.\"\n        },\n        {\n          \"rank\": 3,\n          \"score\": 0.39430007338523865,\n          \"doc_id\": \"208\",\n          \"text\": \"For Big Data, Big Questions Remain For Big Data, Big Questions Remain For Big Data, Big Questions Remain Medicare&#x2019;s release of practitioner payments highlights the strengths and weaknesses of digging into big data.\"\n        }\n      ]\n    },\n    {\n      \"query\": \"How do machine learning and deep learning approaches help overcome these challenges in pharmacogenomics research for antidepressant treatment prediction?\",\n      \"query_meta\": {\n        \"type\": \"single_hop\",\n        \"index\": 1\n      },\n      \"top_k\": 10,\n      \"hits\": [\n        {\n          \"rank\": 1,\n          \"score\": 0.5382652282714844,\n          \"doc_id\": \"53\",\n          \"text\": \"Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms.\"\n        },\n        {\n          \"rank\": 2,\n          \"score\": 0.47233086824417114,\n          \"doc_id\": \"104\",\n          \"text\": \"Deep learning Deep learning Deep learning Artificial intelligence is one of the most beautiful dreams of mankind. Although computer technology has made considerable progress, so far, there is no computer showing intelligence like human beings. The emergence of deep learning gives people a glimmer of hope. So, what is learning deep? Why is it so important? How does it work? And what are the existing achievements and difficulties? This paper provides an overview of deep learning which will answer these questions.\"\n        },\n        {\n          \"rank\": 3,\n          \"score\": 0.45852208137512207,\n          \"doc_id\": \"202\",\n          \"text\": \"Machine learning Machine learning Machine learning A short review of research and applications in machine learning is given. Rather than attempt to cover all areas of ML, the focus is on its role in building expert systems, its approach to classification problems and ML methods of learning control. A relatively new area, inductive logic programming, is also discussed.\"\n        }\n      ]\n    }\n  ],\n  \"meta\": {\n    \"model\": \"gemini-2.5-flash\",\n    \"temperature\": 0.2\n  }\n}\n\n--- Question ---\nWhat is the essence of applying various machine and deep learning approaches to pharmacogenomics research for antidepressant treatment prediction?\n",
    "model": "models/gemini-2.5-pro",
    "retrival": {
        "id": "row_000045",
        "model_name": "Snowflake/snowflake-arctic-embed-l-v2.0",
        "timestamp_kst": "2025-09-07T15:53:08.476963+09:00",
        "trial_id": "7843efac",
        "queries": [
            {
                "query": "What is the essence of applying various machine and deep learning approaches to pharmacogenomics research for antidepressant treatment prediction?",
                "query_meta": {
                    "type": "original"
                },
                "top_k": 10,
                "hits": [
                    {
                        "rank": 1,
                        "score": 0.4918850064277649,
                        "doc_id": "53",
                        "text": "Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms."
                    },
                    {
                        "rank": 2,
                        "score": 0.46110841631889343,
                        "doc_id": "164",
                        "text": "Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade Machine Learning na Medicina: Revis&atilde;o e Aplicabilidade 없음"
                    },
                    {
                        "rank": 3,
                        "score": 0.44697660207748413,
                        "doc_id": "202",
                        "text": "Machine learning Machine learning Machine learning A short review of research and applications in machine learning is given. Rather than attempt to cover all areas of ML, the focus is on its role in building expert systems, its approach to classification problems and ML methods of learning control. A relatively new area, inductive logic programming, is also discussed."
                    }
                ]
            },
            {
                "query": "What are the primary challenges in predicting antidepressant treatment response using pharmacogenomic data?",
                "query_meta": {
                    "type": "single_hop",
                    "index": 0
                },
                "top_k": 10,
                "hits": [
                    {
                        "rank": 1,
                        "score": 0.402208149433136,
                        "doc_id": "140",
                        "text": "Sharing Big Data Sharing Big Data Sharing Big Data Macromolecular Big Data provide numerous challenges and a number of initiatives that are starting to overcome these issues are discussed."
                    },
                    {
                        "rank": 2,
                        "score": 0.39924973249435425,
                        "doc_id": "53",
                        "text": "Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms."
                    },
                    {
                        "rank": 3,
                        "score": 0.39430007338523865,
                        "doc_id": "208",
                        "text": "For Big Data, Big Questions Remain For Big Data, Big Questions Remain For Big Data, Big Questions Remain Medicare&#x2019;s release of practitioner payments highlights the strengths and weaknesses of digging into big data."
                    }
                ]
            },
            {
                "query": "How do machine learning and deep learning approaches help overcome these challenges in pharmacogenomics research for antidepressant treatment prediction?",
                "query_meta": {
                    "type": "single_hop",
                    "index": 1
                },
                "top_k": 10,
                "hits": [
                    {
                        "rank": 1,
                        "score": 0.5382652282714844,
                        "doc_id": "53",
                        "text": "Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD).In this review, we focus on the latest developments for pharmacogenomics research using machine learning and deep learning approaches together with neuroimaging and multi-omics data. First, we review relevant pharmacogenomics studies that leverage numerous machine learning and deep learning techniques to determine treatment prediction and potential biomarkers for antidepressant treatments in MDD. In addition, we depict some neuroimaging pharmacogenomics studies that utilize various machine learning approaches to predict antidepressant treatment outcomes in MDD based on the integration of research on pharmacogenomics and neuroimaging. Moreover, we summarize the limitations in regard to the past pharmacogenomics studies of antidepressant treatments in MDD. Finally, we outline a discussion of challenges and directions for future research. In light of latest advancements in neuroimaging and multi-omics, various genomic variants and biomarkers associated with antidepressant treatments in MDD are being identified in pharmacogenomics research by employing machine learning and deep learning algorithms."
                    },
                    {
                        "rank": 2,
                        "score": 0.47233086824417114,
                        "doc_id": "104",
                        "text": "Deep learning Deep learning Deep learning Artificial intelligence is one of the most beautiful dreams of mankind. Although computer technology has made considerable progress, so far, there is no computer showing intelligence like human beings. The emergence of deep learning gives people a glimmer of hope. So, what is learning deep? Why is it so important? How does it work? And what are the existing achievements and difficulties? This paper provides an overview of deep learning which will answer these questions."
                    },
                    {
                        "rank": 3,
                        "score": 0.45852208137512207,
                        "doc_id": "202",
                        "text": "Machine learning Machine learning Machine learning A short review of research and applications in machine learning is given. Rather than attempt to cover all areas of ML, the focus is on its role in building expert systems, its approach to classification problems and ML methods of learning control. A relatively new area, inductive logic programming, is also discussed."
                    }
                ]
            }
        ],
        "meta": {
            "model": "gemini-2.5-flash",
            "temperature": 0.2
        }
    }
}